{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:55:27Z","timestamp":1791291327941,"version":"4.3.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:00:00Z","timestamp":1456876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0149919","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T18:40:25Z","timestamp":1456944025000},"page":"e0149919","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Novel Acylguanidine Derivatives Targeting Smoothened Induce Antiproliferative and Pro-Apoptotic Effects in Chronic Myeloid Leukemia Cells"],"prefix":"10.1371","volume":"11","author":[{"given":"Alessandra","family":"Chiarenza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Manetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Petricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martial","family":"Ruat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Naldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"issue":"5405","key":"ref1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"JD Rowley","year":"1973","journal-title":"Nature"},{"issue":"6020","key":"ref2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","article-title":"Fused transcript of abl and bcr genes in chronic myelogenous leukaemia","volume":"315","author":"E Shtivelman","year":"1985","journal-title":"Nature"},{"issue":"4760","key":"ref3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","article-title":"The chronic myelogenous leukemia-specific P210 protein is the product of the bcr\/abl hybrid gene","volume":"233","author":"Y Ben-Neriah","year":"1986","journal-title":"Science"},{"issue":"23","key":"ref4","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1073\/pnas.85.23.9312","article-title":"Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr\/abl protein","volume":"85","author":"GQ Daley","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19\u201320","key":"ref5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.drudis.2013.06.001","article-title":"The background, discovery and clinical development of BCR-ABL inhibitors","volume":"18","author":"GK Lambert","year":"2013","journal-title":"Drug Discov Today"},{"issue":"1","key":"ref6","first-page":"100","article-title":"Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative","volume":"56","author":"E Buchdunger","year":"1996","journal-title":"Cancer Res"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"BJ Druker","year":"1996","journal-title":"Nat Med"},{"issue":"6","key":"ref8","article-title":"FDA approves Gleevec for leukemia treatment","volume":"35","year":"2001","journal-title":"FDA Consum"},{"key":"ref9","unstructured":"Drugs Approved for Chronic Myelogenous Leukemia (CML). Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/leukemia#7\" xlink:type=\"simple\">http:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/leukemia#7<\/ext-link>."},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","article-title":"Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance","volume":"96","author":"FX Mahon","year":"2000","journal-title":"Blood"},{"issue":"20","key":"ref11","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1200\/JCO.2007.15.8154","article-title":"Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis","volume":"26","author":"LH de","year":"2008","journal-title":"J Clin Oncol"},{"issue":"8","key":"ref12","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-01-070045","article-title":"Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase","volume":"110","author":"E Jabbour","year":"2007","journal-title":"Blood"},{"issue":"Suppl 3","key":"ref13","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.3816\/CLM.2007.s.012","article-title":"Bcr-Abl kinase domain mutations and the unsettled problem of Bcr-AblT315I: looking into the future of controlling drug resistance in chronic myeloid leukemia","volume":"7","author":"T O'Hare","year":"2007","journal-title":"Clin Lymphoma Myeloma"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl","volume":"7","author":"E Weisberg","year":"2005","journal-title":"Cancer Cell"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1182\/blood-2006-11-057521","article-title":"Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells","volume":"109","author":"HG Jorgensen","year":"2007","journal-title":"Blood"},{"issue":"27","key":"ref16","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"LJ Lombardo","year":"2004","journal-title":"J Med Chem"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.bmcl.2005.11.042","article-title":"Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors","volume":"16","author":"T Asaki","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2009.09.028","article-title":"AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance","volume":"16","author":"T O'Hare","year":"2009","journal-title":"Cancer Cell"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1182\/blood-2012-03-380147","article-title":"How I treat CML blast crisis","volume":"120","author":"R Hehlmann","year":"2012","journal-title":"Blood"},{"issue":"24","key":"ref20","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.4161\/cc.5.24.3573","article-title":"Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia","volume":"5","author":"DJ Barnes","year":"2006","journal-title":"Cell Cycle"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-9966-30-8","article-title":"Activation of the Hedgehog pathway in chronic myelogeneous leukemia patients","volume":"30","author":"B Long","year":"2011","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2010-12-326843","article-title":"Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival","volume":"119","author":"A Hamilton","year":"2012","journal-title":"Blood"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2012.08.006","article-title":"Selective elimination of leukemia stem cells: hitting a moving target","volume":"338","author":"LA Crews","year":"2013","journal-title":"Cancer Lett"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1084\/jem.20110304","article-title":"BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia","volume":"208","author":"C Hurtz","year":"2011","journal-title":"J Exp Med"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1182\/blood-2011-10-387381","article-title":"HIF1alpha is required for survival maintenance of chronic myeloid leukemia stem cells","volume":"119","author":"H Zhang","year":"2012","journal-title":"Blood"},{"issue":"17","key":"ref26","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.4161\/cc.9.17.12945","article-title":"Hedgehog pathway activation in chronic myeloid leukemia","volume":"9","author":"Z Jagani","year":"2010","journal-title":"Cell Cycle"},{"issue":"7239","key":"ref27","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","article-title":"Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia","volume":"458","author":"C Zhao","year":"2009","journal-title":"Nature"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","article-title":"Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation","volume":"14","author":"C Dierks","year":"2008","journal-title":"Cancer Cell"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1158\/1078-0432.CCR-09-2846","article-title":"Targeting Hedgehog\u2014a cancer stem cell pathway","volume":"16","author":"AA Merchant","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"21","key":"ref30","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1158\/0008-5472.CAN-04-1085","article-title":"Activation of the BCL2 promoter in response to Hedgehog\/GLI signal transduction is predominantly mediated by GLI2","volume":"64","author":"G Regl","year":"2004","journal-title":"Cancer Res"},{"issue":"23","key":"ref31","doi-asserted-by":"crossref","first-page":"9055","DOI":"10.1128\/MCB.20.23.9055-9067.2000","article-title":"Sonic hedgehog promotes G(1) cyclin expression and sustained cell cycle progression in mammalian neuronal precursors","volume":"20","author":"AM Kenney","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1242\/dev.00182","article-title":"Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors","volume":"130","author":"AM Kenney","year":"2003","journal-title":"Development"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1074\/jbc.M310589200","article-title":"Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1","volume":"279","author":"RL Bigelow","year":"2004","journal-title":"J Biol Chem"},{"issue":"6886","key":"ref34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/417299a","article-title":"Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E","volume":"417","author":"M Duman-Scheel","year":"2002","journal-title":"Nature"},{"issue":"13","key":"ref35","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1242\/dev.124.13.2537","article-title":"Gli1 is a target of Sonic hedgehog that induces ventral neural tube development","volume":"124","author":"J Lee","year":"1997","journal-title":"Development"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1101\/gad.10.3.301","article-title":"Conservation of the hedgehog\/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog","volume":"10","author":"LV Goodrich","year":"1996","journal-title":"Genes Dev"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-4924-1-10","article-title":"Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists","volume":"1","author":"M Frank-Kamenetsky","year":"2002","journal-title":"J Biol"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1158\/1078-0432.CCR-10-3370","article-title":"Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothened","volume":"17","author":"T Tang","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/leu.2011.67","article-title":"The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem\/progenitor cells","volume":"25","author":"F Pellicano","year":"2011","journal-title":"Leukemia"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/1947601910372232","article-title":"Destabilization of Bcr-Abl\/Jak2 Network by a Jak2\/Abl Kinase Inhibitor ON044580 Overcomes Drug Resistance in Blast Crisis Chronic Myelogenous Leukemia (CML)","volume":"1","author":"AK Samanta","year":"2010","journal-title":"Genes Cancer"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.biopha.2011.12.008","article-title":"Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells","volume":"66","author":"HF Liao","year":"2012","journal-title":"Biomed Pharmacother"},{"issue":"19","key":"ref42","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1038\/emboj.2008.172","article-title":"Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells","volume":"27","author":"E Ferretti","year":"2008","journal-title":"EMBO J"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ijc.28043","article-title":"Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+ CML stem\/progenitor cells","volume":"133","author":"S Babashah","year":"2013","journal-title":"Int J Cancer"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1124\/mol.110.065102","article-title":"Virtual screening-based discovery and mechanistic characterization of the acylthiourea MRT-10 family as smoothened antagonists","volume":"78","author":"F Manetti","year":"2010","journal-title":"Mol Pharmacol"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1021\/jm2013369","article-title":"Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity","volume":"55","author":"A Solinas","year":"2012","journal-title":"J Med Chem"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/mol.110.069708","article-title":"Identification and mechanism of action of the acylguanidine MRT-83, a novel potent Smoothened antagonist","volume":"79","author":"H Roudaut","year":"2011","journal-title":"Mol Pharmacol"},{"issue":"16","key":"ref47","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1101\/gad.1794109","article-title":"Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved","volume":"23","author":"MH Chen","year":"2009","journal-title":"Genes Dev"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/jcp.22761","article-title":"Hypoxia affects dendritic cell survival: role of the hypoxia-inducible factor-1alpha and lipopolysaccharide","volume":"227","author":"A Naldini","year":"2012","journal-title":"J Cell Physiol"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/BJ20111451","article-title":"Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling","volume":"441","author":"J Lee","year":"2012","journal-title":"Biochem J"},{"issue":"12","key":"ref50","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1080\/10428190802510315","article-title":"The hedgehog inhibitor cyclopamine induces apoptosis in leukemic cells in vitro","volume":"49","author":"J Warzecha","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1158\/1078-0432.CCR-12-1777","article-title":"Combination of ponatinib with Hedgehog antagonist vismodegib for therapy-resistant BCR-ABL1-positive leukemia","volume":"19","author":"S Katagiri","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"15","key":"ref52","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/nar\/gks596","article-title":"Primer3\u2014new capabilities and interfaces","volume":"40","author":"A Untergasser","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"ref53","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","article-title":"Enhancements and modifications of primer design program Primer3","volume":"23","author":"T Koressaar","year":"2007","journal-title":"Bioinformatics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0149919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T04:56:44Z","timestamp":1654491404000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0149919"}},"subtitle":[],"editor":[{"given":"Persio","family":"Dello Sbarba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0149919","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]}}}